Company registration number 12460378 (England and Wales)
BEETHAM NURSERIES HOLDINGS LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
BEETHAM NURSERIES HOLDINGS LIMITED
COMPANY INFORMATION
Directors
Mr S J Abbit
Mrs L A Abbit
Company number
12460378
Registered office
Pool Darkin Lane
Beetham
Milnthorpe
LA7 7AP
Auditor
MHA
14 Mannin Way
Lancaster Business Park
Lancaster
LA1 3SW
BEETHAM NURSERIES HOLDINGS LIMITED
CONTENTS
Page
Strategic report
1
Directors' report
2
Directors' responsibilities statement
3
Independent auditor's report
4 - 6
Profit and loss account
7
Group statement of comprehensive income
8
Group balance sheet
9
Company balance sheet
10
Group statement of changes in equity
11
Company statement of changes in equity
12
Group statement of cash flows
13
Notes to the financial statements
14 - 28
BEETHAM NURSERIES HOLDINGS LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 JANUARY 2026
- 1 -
The directors present the strategic report for the year ended 31 January 2026.
Review of the business
Turnover for the year was £6,285,277, an increase of approximately 11.09% on the previous year of £5,657,860. Overall, gross profit increased to £3,285,179 with a gross profit margin of 52.27%. Group profit for the year fell to £170,647.
We continue to have an increase in operational costs with the good weather causing an increase of watering costs by 40%. Staffing remains the single largest operational cost and has increased by 7%.
The Group maintains a strong balance sheet heading into the next financial year with net assets amounting to £4,675,542 and a healthy cash position.
The directors are happy with the recent performance of the Group and would like to thank the staff for their continued commitment to the company during this period.
Principal risks and uncertainties
The directors consider that the business faces no specific risk in the forthcoming period other than the general risks associated with retail activities and those relating to wider economic trends. Where risks can be identified, they will be addressed and actions taken, where possible, to control them.
Challenges over the supply of products from overseas continues to be an issue due to various external factors. The directors are continuing to build on close relationships with existing suppliers.
Food price, utility cost and wage inflation along with challenges in relation to the recruitment and retention of staff are all risks that the directors are monitoring closely.
The directors continually implement new operating procedures and are investing in renewables to help mitigate these risks in an ever-changing environment and they closely monitor key performance indicators to help review performance in these areas.
Key performance indicators
The Group measures Key Performance Indicators for Profitability and Liquidity on a monthly and quarterly basis. These are used to assess financial performance, as well as ensuring operational efficiency.
Future Developments
The directors remain committed to a policy of continued improvement and development of the garden centre.
The company aims to maintain and improve customer goodwill by providing quality products at reasonable and competitive prices.
The growing nursery continues to go from strength to strength providing a large range of quality herbaceous plants and the events and workshops are ever popular and highly successful.
Future increase in operational costs will be managed by improving efficiency within the business and by analysing monthly management accounts to highlight areas for improvement.
Mr S J Abbit
Director
29 October 2026
BEETHAM NURSERIES HOLDINGS LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 JANUARY 2026
- 2 -
The directors present their annual report and financial statements for the year ended 31 January 2026.
Principal activities
The principal activity of the company was that of a holding company. The principal activity of the group was that of a garden centre and tea room.
Results and dividends
The results for the year are set out on page 7.
Ordinary dividends were paid amounting to £49,000. The directors do not recommend payment of a further dividend.
Directors
The directors who held office during the year and up to the date of signature of the financial statements were as follows:
Mr S J Abbit
Mrs L A Abbit
Auditor
The auditor, MHA, is deemed to be reappointed under section 487(2) of the Companies Act 2006.
Strategic report
The truegroup has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the group's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of principal risks and uncertainties and future developments.
Statement of disclosure to auditor
So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the auditor of the company is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the auditor of the company is aware of that information.
On behalf of the board
Mr S J Abbit
Director
29 October 2026
BEETHAM NURSERIES HOLDINGS LIMITED
DIRECTORS' RESPONSIBILITIES STATEMENT
FOR THE YEAR ENDED 31 JANUARY 2026
- 3 -
The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.
United Kingdom company law requires the directors to prepare financial statements for each financial year. Under that law, the directors have elected to prepare the group and parent company financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law, the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the group and parent company, and of the profit or loss of the group for that period.
In preparing these financial statements, the directors are required to:
select suitable accounting policies and then apply them consistently;
make judgements and accounting estimates that are reasonable and prudent;
state whether applicable United Kingdom Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and
prepare the financial statements on the going concern basis unless it is inappropriate to presume that the group and parent company will continue in business.
The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the group’s and parent company’s transactions and disclose with reasonable accuracy at any time the financial position of the group and parent company, and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the group and parent company, and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.
BEETHAM NURSERIES HOLDINGS LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBERS OF BEETHAM NURSERIES HOLDINGS LIMITED
- 4 -
Opinion
We have audited the financial statements of Beetham Nurseries Holdings Limited (the 'parent company') and its subsidiaries (the 'group') for the year ended 31 January 2026 which comprise the group profit and loss account, the group statement of comprehensive income, the group balance sheet, the company balance sheet, the group statement of changes in equity, the company statement of changes in equity, the group statement of cash flows and notes to the financial statements, including material accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).
In our opinion the financial statements:
give a true and fair view of the state of the group's and the parent company's affairs as at 31 January 2026 and of the group's profit for the year then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.
We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our ethical responsibilities in accordance with those requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.
Conclusions relating to going concern
In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.
Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group's and parent company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.
Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.
The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.
We have nothing to report in this regard.
BEETHAM NURSERIES HOLDINGS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF BEETHAM NURSERIES HOLDINGS LIMITED
- 5 -
Opinions on other matters prescribed by the Companies Act 2006
In our opinion, based on the work undertaken in the course of our audit:
The information given in the strategic report and the directors' report for the financial year for which the financial statements are prepared is consistent with the financial statements; and
The strategic report and the directors' report have been prepared in accordance with applicable legal requirements.
In the light of the knowledge and understanding of the group and the parent company and their environment obtained in the course of the audit, we have not identified material misstatements in the strategic report or the directors' report.
Matters on which we are required to report by exception
We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:
adequate accounting records have not been kept by the parent company, or returns adequate for our audit have not been received from branches not visited by us; or
the parent company financial statements are not in agreement with the accounting records and returns; or
certain disclosures of directors' remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.
Responsibilities of directors
As explained more fully in the directors' responsibilities statement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the group's and parent company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the group or parent company or to cease operations, or have no realistic alternative but to do so.
Auditor responsibilities for the audit of the financial statements
Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.
Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The specific procedures for this engagement and the extent to which these are capable of detecting irregularities, including fraud, is detailed below:
Enquiries with management about any known or suspect instances of non-compliance with laws and regulations and fraud;
Auditing the risk of fraud in revenue by performing sales transaction testing to obtain evidence that revenue recognised in the financial statements has occurred;
Challenging assumptions and judgements made by management in their accounting estimates, in particular in relation to fixed assets and provisions for the impairment of assets which requires an exercise of management judgement;
An evaluation of the risk of management override of controls and subsequent testing, including through testing journal entries and other adjustments for appropriateness; and
An evaluation of the group's and parent company's internal control environment.
BEETHAM NURSERIES HOLDINGS LIMITED
INDEPENDENT AUDITOR'S REPORT (CONTINUED)
TO THE MEMBERS OF BEETHAM NURSERIES HOLDINGS LIMITED
- 6 -
Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.
A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.
This report is made solely to the parent company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the parent company’s members those matters we are required to state to them in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the parent company and the parent company’s members as a body, for our audit work, for this report, or for the opinions we have formed.
Jack Steer BA(Hons) FCA
Senior Statutory Auditor
For and on behalf of MHA, Statutory Auditor
Lancaster, United Kingdom
30 October 2026
MHA is the trading name of MHA Audit Services LLP, a limited liability partnership in England and Wales (registered number OC455542)
BEETHAM NURSERIES HOLDINGS LIMITED
GROUP PROFIT AND LOSS ACCOUNT
FOR THE YEAR ENDED 31 JANUARY 2026
- 7 -
2026
2025
Notes
£
£
Turnover
3
6,285,277
5,657,860
Cost of sales
(3,000,098)
(2,646,207)
Gross profit
3,285,179
3,011,653
Administrative expenses
(2,929,058)
(2,618,145)
Other operating income
60,000
Operating profit
4
416,121
393,508
Interest receivable and similar income
7
2
3
Interest payable and similar expenses
8
(115,519)
(120,440)
Profit before taxation
300,604
273,071
Tax on profit
9
(129,957)
(84,551)
Profit for the financial year
24
170,647
188,520
Profit for the financial year is all attributable to the owners of the parent company.
BEETHAM NURSERIES HOLDINGS LIMITED
GROUP STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 JANUARY 2026
- 8 -
2026
2025
£
£
Profit for the year
170,647
188,520
Other comprehensive income
-
-
Total comprehensive income for the year
170,647
188,520
Total comprehensive income for the year is all attributable to the owners of the parent company.
BEETHAM NURSERIES HOLDINGS LIMITED
GROUP BALANCE SHEET
AS AT
31 JANUARY 2026
31 January 2026
- 9 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
11
5,819,461
5,829,068
5,819,461
5,829,068
Current assets
Stocks
15
776,458
797,181
Debtors
16
33,837
26,341
Cash at bank and in hand
464,486
499,056
1,274,781
1,322,578
Creditors: amounts falling due within one year
17
(1,103,488)
(1,237,406)
Net current assets
171,293
85,172
Total assets less current liabilities
5,990,754
5,914,240
Creditors: amounts falling due after more than one year
18
(1,170,514)
(1,240,772)
Provisions for liabilities
Deferred tax liability
21
144,698
119,573
(144,698)
(119,573)
Net assets
4,675,542
4,553,895
Capital and reserves
Called up share capital
23
200
200
Other reserves
24
3,739,365
3,739,365
Profit and loss reserves
24
935,977
814,330
Total equity
4,675,542
4,553,895
These financial statements have been prepared in accordance with the provisions relating to medium-sized groups.
The financial statements were approved by the board of directors and authorised for issue on 29 October 2026 and are signed on its behalf by:
29 October 2026
Mr S J Abbit
Director
Company registration number 12460378 (England and Wales)
BEETHAM NURSERIES HOLDINGS LIMITED
COMPANY BALANCE SHEET
AS AT 31 JANUARY 2026
31 January 2026
- 10 -
2026
2025
Notes
£
£
£
£
Fixed assets
Tangible assets
11
26,415
47,638
Investment property
12
1,597,949
1,597,949
Investments
13
3,739,563
3,739,563
5,363,927
5,385,150
Current assets
Debtors
16
638
5,840
Cash at bank and in hand
43,734
36,117
44,372
41,957
Creditors: amounts falling due within one year
17
(1,528,470)
(1,603,279)
Net current liabilities
(1,484,098)
(1,561,322)
Total assets less current liabilities
3,879,829
3,823,828
Provisions for liabilities
Deferred tax liability
21
2,330
9,234
(2,330)
(9,234)
Net assets
3,877,499
3,814,594
Capital and reserves
Called up share capital
23
200
200
Other reserves
24
3,739,365
3,739,365
Profit and loss reserves
24
137,934
75,029
Total equity
3,877,499
3,814,594
As permitted by section 408 of the Companies Act 2006, the company has not presented its own profit and loss account and related notes. The company’s profit for the year was £111,906 (2025 - £123,966 profit).
These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.
The financial statements were approved by the board of directors and authorised for issue on 29 October 2026 and are signed on its behalf by:
29 October 2026
Mr S J Abbit
Director
Company registration number 12460378 (England and Wales)
BEETHAM NURSERIES HOLDINGS LIMITED
GROUP STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JANUARY 2026
- 11 -
Share capital
Merger relief reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 February 2024
200
3,739,365
674,810
4,414,375
Year ended 31 January 2025:
Profit and total comprehensive income
-
-
188,520
188,520
Dividends
10
-
-
(49,000)
(49,000)
Balance at 31 January 2025
200
3,739,365
814,330
4,553,895
Year ended 31 January 2026:
Profit and total comprehensive income
-
-
170,647
170,647
Dividends
10
-
-
(49,000)
(49,000)
Balance at 31 January 2026
200
3,739,365
935,977
4,675,542
BEETHAM NURSERIES HOLDINGS LIMITED
COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 JANUARY 2026
- 12 -
Share capital
Merger relief reserve
Profit and loss reserves
Total
Notes
£
£
£
£
Balance at 1 February 2024
200
3,739,365
63
3,739,628
Year ended 31 January 2025:
Profit and total comprehensive income for the year
-
-
123,966
123,966
Dividends
10
-
-
(49,000)
(49,000)
Balance at 31 January 2025
200
3,739,365
75,029
3,814,594
Year ended 31 January 2026:
Profit and total comprehensive income
-
-
111,905
111,905
Dividends
10
-
-
(49,000)
(49,000)
Balance at 31 January 2026
200
3,739,365
137,934
3,877,499
BEETHAM NURSERIES HOLDINGS LIMITED
GROUP STATEMENT OF CASH FLOWS
FOR THE YEAR ENDED 31 JANUARY 2026
- 13 -
2026
2025
Notes
£
£
£
£
Cash flows from operating activities
Cash generated from operations
26
496,093
767,385
Interest paid
(115,519)
(120,440)
Income taxes paid
(125,889)
(83,168)
Net cash inflow from operating activities
254,685
563,777
Investing activities
Purchase of tangible fixed assets
(127,820)
(231,963)
Proceeds from disposal of tangible fixed assets
28,400
5,500
Interest received
2
3
Net cash used in investing activities
(99,418)
(226,460)
Financing activities
Repayment of bank loans
(91,020)
(103,472)
Payment of finance leases obligations
(49,817)
(81,453)
Dividends paid to equity shareholders
(49,000)
(49,000)
Net cash used in financing activities
(189,837)
(233,925)
Net (decrease)/increase in cash and cash equivalents
(34,570)
103,392
Cash and cash equivalents at beginning of year
499,056
395,664
Cash and cash equivalents at end of year
464,486
499,056
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JANUARY 2026
- 14 -
1
Accounting policies
Company information
Beetham Nurseries Holdings Limited (“the company”) is a private limited company domiciled and incorporated in England and Wales. The registered office is Pool Darkin Lane, Beetham, Milnthorpe, LA7 7AP.
The group consists of Beetham Nurseries Holdings Limited and its subsidiary, Beetham Nurseries Limited.
1.1
Basis of preparation
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention, modified to include investment properties and certain financial instruments at fair value. The principal accounting policies adopted are set out below.
The company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. The company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements:
Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;
Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: Interest income/expense and net gains/losses for financial instruments not measured at fair value; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;
Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.
1.2
Business combinations
In the parent company financial statements, the cost of a business combination is the fair value at the acquisition date of the assets given, equity instruments issued and liabilities incurred or assumed, plus costs directly attributable to the business combination. The excess of the cost of a business combination over the fair value of the identifiable assets, liabilities and contingent liabilities acquired is recognised as goodwill. The cost of the combination includes the estimated amount of contingent consideration that is probable and can be measured reliably, and is adjusted for changes in contingent consideration after the acquisition date. Provisional fair values recognised for business combinations in previous periods are adjusted retrospectively for final fair values determined in the 12 months following the acquisition date. Investments in subsidiaries, joint ventures and associates are accounted for at cost less impairment.
Deferred tax is recognised on differences between the value of assets (other than goodwill) and liabilities recognised in a business combination accounted for using the purchase method and the amounts that can be deducted or assessed for tax, considering the manner in which the carrying amount of the asset or liability is expected to be recovered or settled. The deferred tax recognised is adjusted against goodwill or negative goodwill.
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 15 -
1.3
Basis of consolidation
The consolidated group financial statements consist of the financial statements of the parent company Beetham Nurseries Holdings Limited together with all entities controlled by the parent company (its subsidiaries).
All financial statements are made up to 31 January 2026. Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.
All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless the transaction provides evidence of an impairment of the asset transferred.
Subsidiaries are consolidated in the group’s financial statements from the date that control commences until the date that control ceases.
1.4
Going concern
At the time of approving the financial statements, the directors have a reasonable expectation that the group and parent company have adequate resources to continue in operational existence for the foreseeable future. Thus the directors continue to adopt the going concern basis of accounting in preparing the financial statements.
1.5
Revenue
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.
1.6
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Freehold land and buildings
2% straight line
Plant and equipment
33.33% straight line
Fixtures and fittings
25% straight line
Motor vehicles
25% reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is recognised in the profit and loss account.
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 16 -
1.7
Fixed asset investments
Equity investments are measured at fair value through profit or loss, except for those equity investments that are not publicly traded and whose fair value cannot otherwise be measured reliably, which are recognised at cost less impairment until a reliable measure of fair value becomes available.
In the parent company financial statements, investments in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses.
A subsidiary is an entity controlled by the group. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.
1.8
Impairment of fixed assets
At each reporting period end date, the group reviews the carrying amounts of its tangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any).
1.9
Stocks
Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Stock value consists of the direct cost of materials.
Cost is calculated using the weighted average method.
At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.
1.10
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand and deposits held at call with banks.
1.11
Financial instruments
The group has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.
Financial instruments are recognised in the group's balance sheet when the group becomes party to the contractual provisions of the instrument.
Financial assets and liabilities are offset and the net amounts presented in the financial statements when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.
Basic financial assets
Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 17 -
Impairment of financial assets
Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.
Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.
If there is a decrease in the impairment loss arising from an event occurring after the impairment was recognised, the impairment is reversed. The reversal is such that the current carrying amount does not exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.
Derecognition of financial assets
Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.
Classification of financial liabilities
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the group after deducting all of its liabilities.
Basic financial liabilities
Basic financial liabilities, including creditors, bank loans and loans from fellow group companies, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.
Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.
Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.
Derecognition of financial liabilities
Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.
1.12
Equity instruments
Equity instruments issued by the group are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the group.
1.13
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
1
Accounting policies
(Continued)
- 18 -
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The group’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset if, and only if, there is a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.14
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense. The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
1.15
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.16
Leases
As lessee
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
Assets held under finance leases are recognised as assets at the lower of the assets fair value at the date of inception and the present value of the minimum lease payments. The related liability is included in the balance sheet as a finance lease obligation. Lease payments are treated as consisting of capital and interest elements. The interest is charged to profit or loss so as to produce a constant periodic rate of interest on the remaining balance of the liability.
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 19 -
2
Judgements and key sources of estimation uncertainty
In the application of the group’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods. The directors have assessed that there are no judgements or key sources of estimation uncertainty in the accounts which required disclosure.
3
Turnover and other revenue
2026
2025
£
£
Turnover analysed by class of business
Nursery & other
5,019,866
4,467,067
Tearooms
1,265,411
1,190,793
6,285,277
5,657,860
2026
2025
£
£
Turnover analysed by geographical market
United Kingdom
6,285,277
5,657,860
2026
2025
£
£
Other revenue
Interest income
2
3
4
Operating profit
2026
2025
£
£
Operating profit for the year is stated after charging/(crediting):
Fees payable to the group's auditor for the audit of the group's financial statements
13,700
12,450
Depreciation of tangible fixed assets
241,723
251,549
Profit on disposal of tangible fixed assets
(14,740)
(3,258)
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 20 -
5
Employees
The average monthly number of persons (including directors) employed by the group and company during the year was:
Group
Company
2026
2025
2026
2025
Number
Number
Number
Number
Staff
81
81
-
-
Directors
2
2
-
-
Total
83
83
0
0
Their aggregate remuneration comprised:
Group
Company
2026
2025
2026
2025
£
£
£
£
Wages and salaries
1,685,164
1,575,639
Pension costs
251,529
48,049
1,936,693
1,623,688
6
Directors' remuneration
2026
2025
£
£
Remuneration for qualifying services
23,755
22,700
Company pension contributions to defined contribution schemes
224,000
20,932
247,755
43,632
The number of directors for whom retirement benefits are accruing under defined contribution schemes amounted to 2 (2025 - 2).
7
Interest receivable and similar income
2026
2025
£
£
Interest income
Interest on bank deposits
2
3
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 21 -
8
Interest payable and similar expenses
2026
2025
£
£
Interest on bank overdrafts and loans
96,617
108,709
Interest on finance leases and hire purchase contracts
18,902
11,731
Total finance costs
115,519
120,440
9
Taxation
2026
2025
£
£
Current tax
UK corporation tax on profits for the current period
104,832
125,889
Deferred tax
Origination and reversal of timing differences
(6,504)
(32,787)
Adjustment in respect of prior periods
31,629
(8,551)
Total deferred tax
25,125
(41,338)
Total tax charge
129,957
84,551
The actual charge for the year can be reconciled to the expected charge for the year based on the profit or loss and the standard rate of tax as follows:
2026
2025
£
£
Profit before taxation
300,604
273,071
Expected tax charge based on the standard rate of corporation tax in the UK of 25% (2025: 25%)
75,151
68,268
Effects of:
Expenses that are not deductible in determining taxable profit
220
624
Depreciation on assets not qualifying for tax allowances
22,957
23,783
Other permanent differences
427
Deferred tax adjustments in respect of prior years
31,629
(8,551)
Taxation charge in the financial statements
129,957
84,551
10
Dividends
2026
2025
Recognised as distributions to equity holders:
£
£
Interim paid
49,000
49,000
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 22 -
11
Tangible fixed assets
Group
Freehold land and buildings
Plant and equipment
Fixtures and fittings
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 February 2025
6,848,545
114,416
1,149,596
411,691
8,524,248
Additions
65,001
41,133
139,642
245,776
Disposals
(49,484)
(49,484)
At 31 January 2026
6,913,546
114,416
1,190,729
501,849
8,720,540
Depreciation and impairment
At 1 February 2025
1,302,991
102,602
1,015,535
274,052
2,695,180
Depreciation charged in the year
105,881
9,720
71,830
54,292
241,723
Eliminated in respect of disposals
(35,824)
(35,824)
At 31 January 2026
1,408,872
112,322
1,087,365
292,520
2,901,079
Carrying amount
At 31 January 2026
5,504,674
2,094
103,364
209,329
5,819,461
At 31 January 2025
5,545,554
11,814
134,061
137,639
5,829,068
Company
Fixtures and fittings
£
Cost
At 1 February 2025
127,921
Additions
644
At 31 January 2026
128,565
Depreciation and impairment
At 1 February 2025
80,283
Depreciation charged in the year
21,867
At 31 January 2026
102,150
Carrying amount
At 31 January 2026
26,415
At 31 January 2025
47,638
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
11
Tangible fixed assets
(Continued)
- 23 -
Included within tangible fixed assets are assets held under finance leases or hire purchase contracts, as follows:
Group
Company
2026
2025
2026
2025
£
£
£
£
Fixtures and fittings
41,232
15,128
Motor vehicles
146,290
69,836
Freehold land and buildings
101,200
103,312
-
-
288,722
188,276
-
-
12
Investment property
Group
Company
2026
2026
£
£
Fair value
At 1 February 2025 and 31 January 2026
-
1,597,949
No revaluation of the investment property has been carried out during the year due to the company acquiring the property in 2021 and continuing to make repairs ahead of it being brought into use.
The directors therefore do not deem the fair value of the investment property at the year end to be materially different to the cost price.
13
Fixed asset investments
Group
Company
2026
2025
2026
2025
Notes
£
£
£
£
Investments in subsidiaries
14
3,739,563
3,739,563
Movements in fixed asset investments
Company
Shares in subsidiaries
£
Cost or valuation
At 1 February 2025 and 31 January 2026
3,739,563
Carrying amount
At 31 January 2026
3,739,563
At 31 January 2025
3,739,563
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 24 -
14
Subsidiaries
Details of the company's subsidiaries at 31 January 2026 are as follows:
Name of undertaking
Registered office
Class of
% Held
shares held
Direct
Beetham Nurseries Limited
Pool Darkin Lane, Milnthorpe, LA7 7AP
Ordinary
100.00
15
Stocks
Group
Company
2026
2025
2026
2025
£
£
£
£
Finished goods and goods for resale
776,458
797,181
16
Debtors
Group
Company
2026
2025
2026
2025
Amounts falling due within one year:
£
£
£
£
Trade debtors
489
1,651
Other debtors
5,756
10,511
638
5,840
Prepayments and accrued income
27,592
14,179
33,837
26,341
638
5,840
17
Creditors: amounts falling due within one year
Group
Company
2026
2025
2026
2025
Notes
£
£
£
£
Bank loans
19
103,901
105,693
Obligations under finance leases
20
111,871
62,702
Trade creditors
316,668
359,583
Amounts owed to group undertakings
1,465,219
1,439,028
Corporation tax payable
104,832
125,889
Other taxation and social security
154,742
121,275
Other creditors
275,567
426,096
63,251
164,251
Accruals and deferred income
35,907
36,168
1,103,488
1,237,406
1,528,470
1,603,279
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 25 -
18
Creditors: amounts falling due after more than one year
Group
Company
2026
2025
2026
2025
Notes
£
£
£
£
Bank loans and overdrafts
19
1,060,291
1,149,519
Obligations under finance leases
20
110,223
91,253
1,170,514
1,240,772
-
-
19
Loans and overdrafts
Group
Company
2026
2025
2026
2025
£
£
£
£
Bank loans
1,164,192
1,255,212
Payable within one year
103,901
105,693
Payable after one year
1,060,291
1,149,519
Bank loans and overdrafts included above are secured by way of National Westminster Bank Plc holding a legal charge and debenture over the undertaking and all property and assets present and future, including: goodwill, book debts, uncalled capital, building fixtures and fixed plant and machinery.
20
Finance lease obligations
Group
Company
2026
2025
2026
2025
Amounts due:
£
£
£
£
Current liabilities
111,871
62,702
Non-current liabilities
110,223
91,253
222,094
153,955
-
-
Finance lease payments represent rentals payable by the company for certain tangible fixed assets. Leases include purchase options at the end of the lease period, and no restrictions are placed on the use of the assets. The average lease term is 3 years. All leases are on a fixed repayment basis and no arrangements have been entered into for contingent rental payments.
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 26 -
21
Deferred taxation
The following are the major deferred tax liabilities and assets recognised by the group and company:
Liabilities
Liabilities
2026
2025
Group
£
£
Accelerated capital allowances
144,698
119,573
Liabilities
Liabilities
2026
2025
Company
£
£
Accelerated capital allowances
2,330
9,234
Group
Company
2026
2026
Movements in the year:
£
£
Liability at 1 February 2025
119,573
9,234
Charge/(credit) to profit or loss
25,125
(6,904)
Liability at 31 January 2026
144,698
2,330
The directors do not expect the net reversal of the deferred tax liability in the year beginning after the reporting period to be materially different from the movement shown in the current year.
22
Retirement benefit schemes
2026
2025
Defined contribution schemes
£
£
Charge to profit or loss in respect of defined contribution schemes
251,529
48,049
A defined contribution pension scheme is operated for all qualifying employees. The assets of the scheme are held separately from those of the group in an independently administered fund.
23
Share capital
Group and company
2026
2025
2026
2025
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary shares of £1 each
200
200
200
200
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 27 -
24
Reserves
Merger relief reserve
The other reserves represents a merger relief reserve arising from the restructure that occurred within the period ended 31 January 2021.
25
Related party transactions
Transactions with related parties
During the year the group entered into the following transactions with related parties:
Remuneration
2026
2025
£
£
Group
Other related parties
153,791
127,052
The following amounts were outstanding at the reporting end date:
Amounts due to related parties
2026
2025
£
£
Group
Key management personnel
119,381
302,142
Company
Key management personnel
63,251
164,251
26
Cash generated from group operations
2026
2025
£
£
Profit after taxation
170,647
188,520
Adjustments for:
Taxation charged
129,957
84,551
Finance costs
115,519
120,440
Investment income
(2)
(3)
Gain on disposal of tangible fixed assets
(14,740)
(3,258)
Depreciation and impairment of tangible fixed assets
241,723
251,549
Movements in working capital:
Decrease in stocks
20,723
13,612
(Increase)/decrease in debtors
(7,496)
23,367
(Decrease)/increase in creditors
(160,238)
88,607
Cash generated from operations
496,093
767,385
BEETHAM NURSERIES HOLDINGS LIMITED
NOTES TO THE GROUP FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 JANUARY 2026
- 28 -
27
Analysis of changes in net debt - group
1 February 2025
Cash flows
New leases
31 January 2026
£
£
£
£
Cash at bank and in hand
499,056
(34,570)
-
464,486
Borrowings excluding overdrafts
(1,255,212)
91,020
-
(1,164,192)
Payment of finance leases obligations
(153,955)
49,817
(117,956)
(222,094)
(910,111)
106,267
(117,956)
(921,800)
2026-01-312025-02-01falsefalseCCH SoftwareCCH Accounts Production 2026.100Mrs L A AbbitMrs L A AbbitMr S J Abbitfalse12460378bus:Consolidated2025-02-012026-01-31124603782025-02-012026-01-3112460378bus:CompanySecretaryDirector12025-02-012026-01-3112460378bus:Director12025-02-012026-01-3112460378bus:Director22025-02-012026-01-3112460378bus:CompanySecretary12025-02-012026-01-3112460378bus:RegisteredOffice2025-02-012026-01-31124603782026-01-3112460378bus:Consolidated2026-01-3112460378bus:Consolidated2024-02-012025-01-31124603782024-02-012025-01-3112460378bus:Consolidated2025-01-31124603782025-01-3112460378core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2026-01-3112460378core:PlantMachinerybus:Consolidated2026-01-3112460378core:FurnitureFittingsbus:Consolidated2026-01-3112460378core:MotorVehiclesbus:Consolidated2026-01-3112460378core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2025-01-3112460378core:PlantMachinerybus:Consolidated2025-01-3112460378core:FurnitureFittingsbus:Consolidated2025-01-3112460378core:MotorVehiclesbus:Consolidated2025-01-3112460378core:FurnitureFittings2026-01-3112460378core:FurnitureFittings2025-01-3112460378core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2026-01-3112460378core:CurrentFinancialInstrumentsbus:Consolidated2025-01-3112460378core:CurrentFinancialInstrumentscore:WithinOneYearbus:Consolidated2025-01-3112460378core:Non-currentFinancialInstrumentscore:AfterOneYear2026-01-3112460378core:Non-currentFinancialInstrumentscore:AfterOneYear2025-01-3112460378core:CurrentFinancialInstrumentscore:WithinOneYear2026-01-3112460378core:CurrentFinancialInstrumentscore:WithinOneYear2025-01-3112460378core:ShareCapitalbus:Consolidated2026-01-3112460378core:ShareCapitalbus:Consolidated2025-01-3112460378core:OtherMiscellaneousReservebus:Consolidated2026-01-3112460378core:OtherMiscellaneousReservebus:Consolidated2025-01-3112460378core:RetainedEarningsAccumulatedLossesbus:Consolidated2026-01-3112460378core:RetainedEarningsAccumulatedLossesbus:Consolidated2025-01-3112460378core:ShareCapital2026-01-3112460378core:ShareCapital2025-01-3112460378core:OtherMiscellaneousReserve2026-01-3112460378core:OtherMiscellaneousReserve2025-01-3112460378core:RetainedEarningsAccumulatedLosses2026-01-3112460378core:RetainedEarningsAccumulatedLosses2025-01-3112460378core:ShareCapitalbus:Consolidated2024-01-31124603782024-01-3112460378core:ShareCapital2024-01-3112460378bus:Consolidated2024-01-3112460378core:LandBuildingscore:OwnedOrFreeholdAssets2025-02-012026-01-3112460378core:PlantMachinery2025-02-012026-01-3112460378core:FurnitureFittings2025-02-012026-01-3112460378core:MotorVehicles2025-02-012026-01-3112460378core:UKTaxbus:Consolidated2025-02-012026-01-3112460378core:UKTaxbus:Consolidated2024-02-012025-01-3112460378bus:Consolidated12025-02-012026-01-3112460378bus:Consolidated12024-02-012025-01-3112460378core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2025-01-3112460378core:PlantMachinerybus:Consolidated2025-01-3112460378core:FurnitureFittingsbus:Consolidated2025-01-3112460378core:MotorVehiclesbus:Consolidated2025-01-3112460378bus:Consolidated2025-01-3112460378core:FurnitureFittings2025-01-3112460378core:LandBuildingscore:OwnedOrFreeholdAssetsbus:Consolidated2025-02-012026-01-3112460378core:PlantMachinerybus:Consolidated2025-02-012026-01-3112460378core:FurnitureFittingsbus:Consolidated2025-02-012026-01-3112460378core:MotorVehiclesbus:Consolidated2025-02-012026-01-3112460378core:MotorVehicles2026-01-3112460378core:MotorVehicles2025-01-3112460378core:Subsidiary12025-02-012026-01-3112460378core:Subsidiary112025-02-012026-01-3112460378core:CurrentFinancialInstrumentsbus:Consolidated2026-01-3112460378core:CurrentFinancialInstruments2026-01-3112460378core:CurrentFinancialInstruments2025-01-3112460378core:CurrentFinancialInstrumentsbus:Consolidated12026-01-3112460378core:CurrentFinancialInstrumentsbus:Consolidated12025-01-3112460378core:CurrentFinancialInstruments22026-01-3112460378core:CurrentFinancialInstruments22025-01-3112460378core:WithinOneYearbus:Consolidated2026-01-3112460378core:WithinOneYearbus:Consolidated2025-01-3112460378core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2026-01-3112460378core:Non-currentFinancialInstrumentscore:AfterOneYearbus:Consolidated2025-01-3112460378core:Non-currentFinancialInstrumentsbus:Consolidated2026-01-3112460378core:Non-currentFinancialInstrumentsbus:Consolidated2025-01-3112460378core:Non-currentFinancialInstruments2026-01-3112460378core:Non-currentFinancialInstruments2025-01-3112460378bus:PrivateLimitedCompanyLtd2025-02-012026-01-3112460378bus:FRS1022025-02-012026-01-3112460378bus:Audited2025-02-012026-01-3112460378bus:ConsolidatedGroupCompanyAccounts2025-02-012026-01-3112460378bus:FullAccounts2025-02-012026-01-31xbrli:purexbrli:sharesiso4217:GBP